Evidence map›Paper›PMID 38168102›Full record

ArticleNature communications2024

Competition between inside-out unfolding and pathogenic aggregation in an amyloid-forming β-propeller.

Emily G Saccuzzo, Mubark D Mebrat, Hailee F Scelsi, Minjoo Kim, Minh Thu Ma, Xinya Su, Shannon E Hill, Elisa Rheaume, Renhao Li, Matthew P Torres and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Protein misfolding and mitochondrial dysfunction in glaucoma.Frontiers in cell and developmental biology · 2025
    Review
  8. Evidence for SbioRxiv : the preprint server for biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Emily G Saccuzzo *School of Chemistry & Biochemistry, Georgia Institute of Technology, Atlanta, USA.
Mubark D Mebrat *Biodesign Center for Personalized Diagnostics, Arizona State University, Tempe, USA.
Hailee F ScelsiSchool of Chemistry & Biochemistry, Georgia Institute of Technology, Atlanta, USA.
Minjoo KimBiodesign Center for Personalized Diagnostics, Arizona State University, Tempe, USA.ORCID 0000-0001-8032-2445
Minh Thu MaSchool of Chemistry & Biochemistry, Georgia Institute of Technology, Atlanta, USA.
Xinya SuSchool of Biological Sciences, Georgia Institute of Technology, Atlanta, USA.
Shannon E HillSchool of Chemistry & Biochemistry, Georgia Institute of Technology, Atlanta, USA.
Elisa RheaumeInterdisciplinary Graduate Program in Quantitative Biosciences, Georgia Institute of Technology, Atlanta, USA.
Renhao LiAflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Department of Pediatrics, Emory University School of Medicine, Atlanta, USA.ORCID 0000-0002-5806-5080
Matthew P TorresSchool of Biological Sciences, Georgia Institute of Technology, Atlanta, USA.
James C GumbartSchool of Chemistry & Biochemistry, Georgia Institute of Technology, Atlanta, USA.
Wade D Van HornBiodesign Center for Personalized Diagnostics, Arizona State University, Tempe, USA. wade.van.horn@asu.edu.ORCID 0000-0002-2493-5578
Raquel L LiebermanSchool of Chemistry & Biochemistry, Georgia Institute of Technology, Atlanta, USA. Raquel.lieberman@chemistry.gatech.edu.ORCID 0000-0001-9345-3735

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
Request for Supplement to Promote Diversity in Health Related ResearchR01EY021205 · NEI · GEORGIA INSTITUTE OF TECHNOLOGY · PI Raquel L Lieberman · 2011 to 2026
$6.8M
VIsion Science Training in AtlantaT32EY007092 · NEI · EMORY UNIVERSITY · PI Machelle T. Pardue · 1985 to 2026
$4.6M
Molecular Mechanisms and Regulation Networks of TRPM8 - Renewal - 1R35GM141933 · NIGMS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI Wade D. Van Horn · 2021 to 2026
$2.5M
Dynamic characterization of outer-membrane-protein biogenesis by the BAM and TAM complexesR01GM123169 · NIGMS · GEORGIA INSTITUTE OF TECHNOLOGY · PI GUMBART, JAMES C. · 2017 to 2021
$1.4M
Pharmacological chaperones for the treatment of Open-Angle GlaucomaR41EY031203 · NEI · VIEWPOINT THERAPEUTICS, INC. · PI MAKLEY, LEAH NICOLE · 2020 to 2020
$225k
NCATS NIH HHS UL1 TR000454NCATS NIH HHS UL1 TR002378NEI NIH HHS R01 EY021205NEI NIH HHS R41 EY031203NEI NIH HHS T32 EY007092NIGMS NIH HHS R01 GM123169NIGMS NIH HHS R35 GM141933
6 · The paper itself

Abstract

Studies of folded-to-misfolded transitions using model protein systems reveal a range of unfolding needed for exposure of amyloid-prone regions for subsequent fibrillization. Here, we probe the relationship between unfolding and aggregation for glaucoma-associated myocilin. Mutations within the olfactomedin domain of myocilin (OLF) cause a gain-of-function, namely cytotoxic intracellular aggregation, which hastens disease progression. Aggregation by wild-type OLF (OLF

Indexed as

AmyloidGlaucomaAmyloid beta-PeptidesAmyloidogenic ProteinsHumansMutationProtein FoldingAmyloidAmyloid beta-PeptidesAmyloidogenic Proteins

Identifiers

PMID38168102
PMCPMC10762032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.